Companies: 10,795·Total market cap: $144.5T
DIH Holding US, Inc.

DIH Holding US, Inc.

DHAIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$837
P/E Ratio
52W High$8.9875
52W Low$0.0001

DIH Holding US, Inc. (DHAI) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

dhai · pe ratio · data through Mar 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for DIH Holding US, Inc. (DHAI) measures how much investors pay for each dollar of the company's trailing earnings. DHAI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$5.69.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31

Forward P/E
N/A
EPS (TTM)
-$5.69
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DIH Holding US, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
DIH Holding US, Inc.
DIH Holding US, Inc.You
DHAI
$0MN/A-$5.69
Bone Biologics Corporation
Bone Biologics Corporation
BBLG
$2MN/A-$2.65
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc
BDRX
$1MN/A-$113.82
GlucoTrack, Inc.
GlucoTrack, Inc.
GCTK
$0MN/A-$21.56
HeartSciences Inc.
HeartSciences Inc.
HSCS
$4MN/A-$9.34
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc.
INM
$3MN/A-$8.36
Corvex, Inc.
Corvex, Inc.
MOVE
$13MN/A-$0.02

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-03-31Latest
FY2025
$-6.07
2024-03-31
FY2024
$-8.00
2023-03-31
FY2023
$-2.36
2022-03-31
FY2022
$-9.11
2021-03-31
FY2021
$-8.20

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for DIH Holding US, Inc. (DHAI) measures how much investors pay for each dollar of the company's trailing earnings. DHAI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$5.69.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$5.69 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

DHAI pe ratio · 6 questions

DHAI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$5.69. Data sourced from Financial Modeling Prep via DHAI's SEC 10-K and 10-Q filings.

DHAI PE ratioWhat is DHAI PE ratioCurrent PE ratio of DHAIDHAI PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DIH Holding US, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09